Cover Image
市場調查報告書

手術中神經監測器 (IONM) 全球市場:產品、服務分類 (系統、配件、服務)、服務形態分類 (內包/外包)、用途分類、方法分類、使用者分類

Intraoperative Neuromonitoring Market by Products & Services (Systems, Accessories, and Services), Source Type (Insourced Monitoring and Outsourced Monitoring), Application, Modality and End User

出版商 Allied Market Research 商品編碼 482412
出版日期 內容資訊 英文 240 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
手術中神經監測器 (IONM) 全球市場:產品、服務分類 (系統、配件、服務)、服務形態分類 (內包/外包)、用途分類、方法分類、使用者分類 Intraoperative Neuromonitoring Market by Products & Services (Systems, Accessories, and Services), Source Type (Insourced Monitoring and Outsourced Monitoring), Application, Modality and End User
出版日期: 2017年02月01日 內容資訊: 英文 240 Pages
簡介

手術中神經監測器 (IONM) 是神經相關手術之後、避免發生各種神經傷害 - 肌力降低、麻痺、喪失聽覺 - 的方法。

本報告針對世界手術中神經監測器 (以下IONM) 市場分析、提供系統、技術概要與市場基本構造、主要市場促進、阻礙因素、產品/服務分類、服務形態分類、用途分類、方法分類、使用者分類、地區分類詳細動向、主要企業檔案(企業概要、最新動向、部門分類分析、業績、策略發展情況) 調查。

第1章 介紹

第2章 摘要整理

第3章 市場概要

  • 市場定義與範圍
  • 分析重點
    • 主要投資財源
    • 獲得主要市場策略
      • 主要企業概略與策略
  • 企業定位
  • 市場動態
    • 市場促進因素
      • 高齡人口增加
      • 慢性疾病患者增加
      • 各種手術的IONM使用情況
      • 複雜手術使用IONM進行風險管理
    • 市場阻礙因素
      • 發展中國加的IONM知名度太低
      • 熟練的專家不足
    • 市場機會
      • 醫療觀光發展
      • 新興國家市場成長機會
    • 影響度分析
  • 臨床試驗
  • 美國醫療費補償狀況

第4章 手術中神經監測器 (IONM) 市場:產品、服務分類

  • 概要
  • 系統
    • 市場規模與預測
  • 配件
  • 服務

第5章 手術中神經監測器市場:BY SOURCE TYPE

  • 概要
  • 內包監測
    • 主要市場動向
    • 主要成長促進因素與市場機會
    • 市場規模與預測
  • 外包監測

第6章 手術中神經監測器市場:方法分類

  • 概要
  • SSEP (體感覺誘發電位)
    • 市場與預測
  • EMG (肌電圖檢查)
  • EEG (腦波檢查)
  • BAEP (腦幹聽覺誘發電位)
  • MEP (運動誘發電位)
  • VEP (視覺誘發電位)

第7章 手術中神經監測器市場:用途分類

  • 概要
  • 脊椎手術
  • 耳鼻喉科 (ENT) 手術
  • 神經手術
  • 心臟手術
  • 眼科手術
  • 其他手術

第8章 手術中神經監測器市場:使用者分類

  • 概要
  • 醫院
  • 流動手術中心 (ASC)

第9章 手術中神經監測器市場:地區分類

  • 概要
  • 北美市場 (美國、加拿大、墨西哥)
    • 主要市場動向
    • 主要成長促進因素與市場機會
    • 市場規模與預測
  • 歐洲市場 (德國、法國、英國、義大利、西班牙)
  • 亞太地區 (日本、中國、印度、韓國、澳洲)
  • 拉丁美洲、中東、非洲 (LAMEA:巴西、南非、沙烏地阿拉伯)

第10章 企業檔案

  • ACCURATE MONITORING, LLC
  • COMPUTATIONAL DIAGNOSTICS, INC.
  • INOMED MEDIZINTECHNIK GMBH
  • INTRANERVE, LLC
  • MEDTRONIC PLC
  • MOBERG RESEARCH, INC
  • NATUS MEDICAL INCORPORATED
  • 日本光電
  • NUVASIVE, INC.
  • SPECIALTYCARE

圖表一覽

目錄
Product Code: LI 171920

Intraoperative Neurophysiologic Monitoring (Ionm) Or Intraoperative Neuromonitoring Is A Technique To Reduce The Risk Of Neurological Deficits After Operations That Involve The Nervous System. Ionm Has Evolved In The Last Two Decades; It Utilizes Recordings Of Electrical Potentials From The Nervous System During Surgical Procedures. The Use Of Neuromonitoring Offers An Opportunity To Detect Injuries Before They Become So Severe That They Cause Deficits After The Operation. Therefore, With The Introduction Of Ionm, The Risk Of Debilitating Deficits Such As Muscle Weakness, Paralysis, Hearing Loss, And Other Loss Of Normal Body Functions Are Reduced.

Ageing Population, Increase In The Number Of Surgical Procedures, Increased Awareness Regarding Benefits Of Ionm In Developed Regions, And Risk Management Through Ionm During Complex Surgeries Drive The Market. However, Low Awareness Of Ionm In Developing Nations And Dearth Of Skilled Professionals Hamper The Growth. Conversely, Applications Of Ionm In Different Surgeries And Growth Opportunities In The Emerging Economies Of The Asia-Pacific And Lamea Regions Are Expected To Provide Several Opportunities For Market Growth During The Forecast Period.

The Report Segments The Market Based On Products & Services, Source Type, Application, Modality, End User, And Region. Based On Products & Services, The Market Is Segmented Into Systems, Accessories And Services. Based On Source Type, The Market Is Bifurcated Into Insourced And Outsourced Monitoring. The End-User Segment Is Categorized Into Hospitals And Ambulatory Surgical Centers (Ascs). Ionm Finds Its Application In Spinal Surgery, Neurosurgery, Vascular Surgery, Ent Surgery, Orthopedic Surgery, And Other Surgeries Related To The Central Or Peripheral Nervous System. Ionm Modalities Include Motor Evoked Potentials (Meps), Somatosensory Evoked Potentials (Sseps), Electroencephalography (Eeg), Electromyography (Emg), Brainstem Auditory Evoked Potentials (Baeps) And Visual Evoked Potentials (Veps). Based On Region, The Market Is Analyzed Across North America (U.S., Canada, And Mexico), Europe (Germany, France, Italy, Uk, Spain, And Rest Of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, And Rest Of Asia-Pacific), And Lamea (Brazil, South Africa, Saudi Arabia, And Rest Of Lamea).

Key Players Operating In The Global Intraoperative Neuromonitoring Market Include Medtronic Plc, Nuvasive, Inc., Computational Diagnostics, Inc., Specialtycare, Natus Medical Incorporated., Intranerve, Llc, Inomed Medizintechnik Gmbh, Accuratemonitoring Llc, Nihon Kohden Corporation, And Day One Medical, Llc.

Key Benefits for Stakeholders

  • The Study Provides An In-Depth Analysis Of The Market With Current Trends And Future Estimations To Elucidate The Imminent Investment Pockets.
  • The Report Provides A Quantitative Analysis From 2014 To 2022, Which Is Expected To Enable The Stakeholders To Capitalize On Prevailing Market Opportunities.
  • Extensive Analysis By Application Helps Understand The Various Types Of Surgeries That May Require Ionm.
  • Competitive Intelligence Highlights The Business Practices Followed By Leading Players Across Various Regions.
  • Comprehensive Analysis Of All Geographical Regions Is Provided, Which Determines The Prevailing Opportunities In These Geographies.
  • Key Players Are Profiled In The Report And Their Strategies Are Analyzed Thoroughly, Which Helps Understand Competitive Outlook Of The Global Market.

Intraoperative Neuromonitoring Market Key Segments

By Products & Services

  • Systems
  • Accessories
  • Services

By Source Type

  • Insourced Monitoring
  • Outsourced Monitoring

By Application

  • Spinal Surgery
  • Neurosurgery
  • Vascular Surgery
  • Ent Surgery
  • Orthopedic Surgery
  • Other Surgeries

By Modality

  • Motor Evoked Potentials (Meps)
  • Somatosensory Evoked Potentials (Sseps)
  • Electroencephalography (Eeg)
  • Electromyography (Emg)
  • Brainstem Auditory Evoked Potentials (Baeps)
  • Visual Evoked Potentials (Veps)

By End User

  • Hospitals
  • Ambulatory Surgical Centers (Ascs)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest Of Asia-Pacific
  • Lamea
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest Of Lamea

Table of Contents

CHAPTER 1 - INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS FOR STAKEHOLDERS
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1. KEY FINDINGS OF THE STUDY
  • 2.2. CXO PERSPECTIVE

CHAPTER 3 - MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top investment pockets
    • 3.2.2. Top winning strategies
      • 3.2.2.1. Competitive intelligence of companies and their strategies
  • 3.3. PLAYER POSITIONING, 2015
  • 3.4. MARKET DYNAMICS
    • 3.4.1. Drivers
      • 3.4.1.1. Growing geriatric population
      • 3.4.1.2. Increasing prevalence of chronic disorders
      • 3.4.1.3. Applications of IONM in different surgeries
      • 3.4.1.4. Risk management through IONM during complex surgeries
    • 3.4.2. Restraints
      • 3.4.2.1. Low awareness of IONM in developing nations
      • 3.4.2.2. Dearth of skilled professionals
    • 3.4.3. Opportunities
      • 3.4.3.1. Increasing medical tourism
      • 3.4.3.2. Growth opportunities in the emerging economies
    • 3.4.4. Impact analysis
  • 3.5. CLINICAL TRIALS
  • 3.6. REIMBURSEMENT SCENARIO IN U.S.

CHAPTER 4 - INTRAOPERATIVE NEUROMONITORING MARKET BY PRODUCTS & SERVICES

  • 4.1. OVERVIEW
    • 4.1.1. Market size and forecast
  • 4.2. SYSTEMS
    • 4.2.1. Market size and forecast
  • 4.3. ACCESSORIES
    • 4.3.1. Market size and forecast
  • 4.4. SERVICES
    • 4.4.1. Market size and forecast

CHAPTER 5 - INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE

  • 5.1. OVERVIEW
    • 5.1.1. Market size and forecast
  • 5.2. INSOURCED MONITORING
    • 5.2.1. Key market trends
    • 5.2.2. Key growth factors and opportunities
    • 5.2.3. Market size and forecast
  • 5.3. OUTSOURCED MONITORING
    • 5.3.1. Key market trends
    • 5.3.2. Key growth factors and opportunities
    • 5.3.3. Market size and forecast

CHAPTER 6 - INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY

  • 6.1. OVERVIEW
    • 6.1.1. Market size and forecast
  • 6.2. SOMATOSENSORY EVOKED POTENTIALS (SSEPS)
    • 6.2.1. Market size and forecast
  • 6.3. ELECTROMYOGRAPHY (EMG)
    • 6.3.1. Market size and forecast
  • 6.4. ELECTROENCEPHALOGRAPHY (EEG)
    • 6.4.1. Market size and forecast
  • 6.5. BRAINSTEM AUDITORY EVOKED POTENTIALS (BAEPS)
    • 6.5.1. Market size and forecast
  • 6.6. MOTOR EVOKED POTENTIALS (MEPS)
    • 6.6.1. Market size and forecast
  • 6.7. VISUAL EVOKED POTENTIALS (VEPS)
    • 6.7.1. Market size and forecast

CHAPTER 7 - INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION

  • 7.1. OVERVIEW
    • 7.1.1. Market size and forecast
  • 7.2. SPINAL SURGERY
    • 7.2.1. Market size and forecast
  • 7.3. ENT SURGERY
    • 7.3.1. Market size and forecast
  • 7.4. NEUROSURGERY
    • 7.4.1. Market size and forecast
  • 7.5. VASCULAR SURGERY
    • 7.5.1. Market size and forecast
  • 7.6. ORTHOPEDIC SURGERY
    • 7.6.1. Market size and forecast
  • 7.7. OTHER SURGERIES
    • 7.7.1. Market size and forecast

CHAPTER 8 - INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER

  • 8.1. OVERVIEW
    • 8.1.1. Market size and forecast
  • 8.2. HOSPITALS
    • 8.2.1. Market size and forecast
  • 8.3. AMBULATORY SURGICAL CENTERS (ASCS)
    • 8.3.1. Market size and forecast

CHAPTER 9 - INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION

  • 9.1. OVERVIEW
    • 9.1.1. Market size and forecast
  • 9.2. NORTH AMERICA
    • 9.2.1. Key market trends
    • 9.2.2. Key growth factors and opportunities
    • 9.2.3. Market size and forecast
    • 9.2.4. U.S.
    • 9.2.5. Canada
    • 9.2.6. Mexico
  • 9.3. EUROPE
    • 9.3.1. Key market trends
    • 9.3.2. Key growth factors and opportunities
    • 9.3.3. Market size and forecast
    • 9.3.4. Germany
    • 9.3.5. France
    • 9.3.6. UK
    • 9.3.7. Italy
    • 9.3.8. Spain
    • 9.3.9. Rest of Europe
  • 9.4. ASIA-PACIFIC
    • 9.4.1. Key market trends
    • 9.4.2. Key growth factors and opportunities
    • 9.4.3. Market size and forecast
    • 9.4.4. Japan
    • 9.4.5. China
    • 9.4.6. India
    • 9.4.7. South Korea
    • 9.4.8. Australia
    • 9.4.9. Rest of Asia-Pacific
  • 9.5. LAMEA
    • 9.5.1. Key market trends
    • 9.5.2. Key growth factors and opportunities
    • 9.5.3. Market size and forecast
    • 9.5.4. Brazil
    • 9.5.5. South Africa
    • 9.5.6. Saudi Arabia
    • 9.5.7. Rest of LAMEA

CHAPTER 10 - COMPANY PROFILES

  • 10.1. ACCURATE MONITORING, LLC
    • 10.1.1. Company overview
    • 10.1.2. Company snapshot
    • 10.1.3. Key strategic moves & developments
  • 10.2. COMPUTATIONAL DIAGNOSTICS, INC.
    • 10.2.1. Company overview
    • 10.2.2. Company snapshot
    • 10.2.3. Key strategic moves & developments
  • 10.3. INOMED MEDIZINTECHNIK GMBH
    • 10.3.1. Company overview
    • 10.3.2. Company snapshot
    • 10.3.3. Operating business segments
    • 10.3.4. Key strategic moves & developments
  • 10.4. INTRANERVE, LLC
    • 10.4.1. Company overview
    • 10.4.2. Company snapshot
    • 10.4.3. Key strategic moves & developments
  • 10.5. MEDTRONIC PLC
    • 10.5.1. Company overview
    • 10.5.2. Company snapshot
    • 10.5.3. Operating business segments
    • 10.5.4. Business performance
    • 10.5.5. Key strategic moves & developments
  • 10.6. MOBERG RESEARCH, INC
    • 10.6.1. Company overview
    • 10.6.2. Company snapshot
    • 10.6.3. Operating business segments
    • 10.6.4. Key strategic moves & developments
  • 10.7. NATUS MEDICAL INCORPORATED.
    • 10.7.1. Company overview
    • 10.7.2. Company snapshot
    • 10.7.3. Operating business segments
    • 10.7.4. Business performance
    • 10.7.5. Key strategic moves & developments
  • 10.8. NIHON KOHDEN CORPORATION
    • 10.8.1. Company overview
    • 10.8.2. Company snapshot
    • 10.8.3. Operating business segments
    • 10.8.4. Business performance
    • 10.8.5. Key strategic moves & developments
  • 10.9. NUVASIVE, INC.
    • 10.9.1. Company overview
    • 10.9.2. Company snapshot
    • 10.9.3. Operating business segments
    • 10.9.4. Business performance
    • 10.9.5. Key strategic moves & developments
  • 10.10. SPECIALTYCARE
    • 10.10.1. Company overview
    • 10.10.2. Company snapshot
    • 10.10.4. Key strategic moves & developments

LIST OF TABLES

  • TABLE 1. CLINICAL TRIALS IN IONM MARKET
  • TABLE 2. COMPLETED CLINICAL TRIALS IN INTRAOPERATIVE NEUROMONITORING MARKET
  • TABLE 3. BASE (PRIMARY) CODES FOR IONM MODALITIES
  • TABLE 4. HOSPITAL INPATIENT CODES
  • TABLE 5. GLOBAL IONM MARKET, BY PRODUCTS & SERVICES ($MILLION), 2014-2022
  • TABLE 6. GLOBAL INTRAOPERATIVE NEUROMONITORING SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 7. GLOBAL INTRAOPERATIVE NEUROMONITORING ACCESSORIES MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 8. GLOBAL INTRAOPERATIVE NEUROMONITORING SERVICES MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE ($MILLION), 2014-2022
  • TABLE 10. GLOBAL INTRAOPERATIVE NEUROMONITORING SOURCE TYPE MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 11. GLOBAL INSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 12. GLOBAL OUTSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 13. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY ($MILLION), 2014-2022
  • TABLE 14. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION ($MILLION), 2014-2022
  • TABLE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING APPLICATIONS MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 16. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR SPINAL SURGERY, BY REGION ($MILLION), 2014-2022
  • TABLE 17. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ENT SURGERY, BY REGION ($MILLION), 2014-2022
  • TABLE 18. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR NEUROSURGERY, BY REGION ($MILLION), 2014-2022
  • TABLE 19. GLOBAL INTRAOPRATIVE NEUROMONITORING FOR VASCULAR SURGERY, BY REGION ($MILLION), 2014-2022
  • TABLE 20. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ORTHOPEDIC SURGERY, BY REGION ($MILLION), 2014-2022
  • TABLE 21. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR OTHER SURGERIES, BY REGION ($MILLION), 2014-2022
  • TABLE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER ($MILLION), 2014-2022
  • TABLE 23. HOSPITALS INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 24. AMBULATORY SURGICAL CENTERS (ASCS) INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 25. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 26. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 27. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
  • TABLE 28. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
  • TABLE 29. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 30. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
  • TABLE 31. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
  • TABLE 32. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 33. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
  • TABLE 34. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
  • TABLE 35. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 36. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
  • TABLE 37. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
  • TABLE 38. ACCURATE MONITORING: COMPANY SNAPSHOT
  • TABLE 39. COMPUTATIONAL DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 40. INOMED: COMPANY SNAPSHOT
  • TABLE 41. INOMED: OPERATING SEGMENTS
  • TABLE 42. INTRANERVE: COMPANY SNAPSHOT
  • TABLE 44. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 45. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 46. MOBERG RESEARCH: COMPANY SNAPSHOT
  • TABLE 47. MOBERG RESEARCH: OPERATING SEGMENTS
  • TABLE 48. NATUS MEDICAL: COMPANY SNAPSHOT
  • TABLE 49. NATUS MEDICAL: OPERATING SEGMENTS
  • TABLE 50. NIHON KOHDEN: COMPANY SNAPSHOT
  • TABLE 51. NIHON KOHDEN: OPERATING SEGMENTS
  • TABLE 52. NUVASIVE: COMPANY SNAPSHOT
  • TABLE 53. NUVASIVE: OPERATING SEGMENTS
  • TABLE 54. SPECIALTYCARE: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 1. INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION
  • FIGURE 2. TOP INVESTMENT POCKETS
  • FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
  • FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
  • FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
  • FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
  • FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
  • FIGURE 8. PLAYER POSITIONING, 2015
  • FIGURE 9. IMPACT ANALYSIS: INTRAOPERATIVE NEUROMONITORING MARKET
  • FIGURE 10. GLOBAL IONM MARKET, BY PRODUCTS & SERVICES ($MILLION), 2014-2022
  • FIGURE 11. GLOBAL INTRAOPERATIVE NEUROMONITORING SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
  • FIGURE 12. GLOBAL INTRAOPERATIVE NEUROMONITORING ACCESSORIES MARKET, BY REGION ($MILLION), 2014-2022
  • FIGURE 13. GLOBAL INTRAOPERATIVE NEUROMONITORING SERVICES MARKET, BY REGION ($MILLION), 2014-2022
  • FIGURE 14. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE ($MILLION), 2014-2022
  • FIGURE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING SOURCE TYPE MARKET, BY REGION ($MILLION), 2014-2022
  • FIGURE 16. GLOBAL INSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
  • FIGURE 17. GLOBAL OUTSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
  • FIGURE 18. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY ($MILLION), 2014-2022
  • FIGURE 19. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR SSEPS ($MILLION), 2014-2022
  • FIGURE 20. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR EMG ($MILLION), 2014-2022
  • FIGURE 21. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR EEG ($MILLION), 2014-2022
  • FIGURE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR BAEPS ($MILLION), 2014-2022
  • FIGURE 23. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR MEPS ($MILLION), 2014-2022
  • FIGURE 24. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR VEPS ($MILLION), 2014-2022
  • FIGURE 25. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION ($MILLION), 2014-2022
  • FIGURE 26. GLOBAL INTRAOPERATIVE NEUROMONITORING APPLICATIONS MARKET, BY REGION ($MILLION), 2014-2022
  • FIGURE 27. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR SPINAL SURGERY, BY REGION ($MILLION), 2014-2022
  • FIGURE 28. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ENT SURGERY, BY REGION ($MILLION), 2014-2022
  • FIGURE 29. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR NEUROSURGERY, BY REGION ($MILLION), 2014-2022
  • FIGURE 30. GLOBAL INTRAOPRATIVE NEUROMONITORING FOR VASCULAR SURGERY, BY REGION ($MILLION), 2014-2022
  • FIGURE 31. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ORTHOPEDIC SURGERY, BY REGION ($MILLION), 2014-2022
  • FIGURE 32. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR OTHER SURGERIES, BY REGION ($MILLION), 2014-2022
  • FIGURE 33. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER ($MILLION), 2014-2022
  • FIGURE 34. HOSPITALS & CLINICS INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
  • FIGURE 35. AMBULATORY SURGICAL CENTERS (ASCS) INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
  • FIGURE 36. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
  • FIGURE 37. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
  • FIGURE 38. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
  • FIGURE 39. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
  • FIGURE 40. U.S. IONM MARKET ($MILLION), 2014-2022
  • FIGURE 41. CANADA IONM MARKET ($MILLION), 2014-2022
  • FIGURE 42. MEXICO IONM MARKET ($MILLION), 2014-2022
  • FIGURE 43. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
  • FIGURE 44. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
  • FIGURE 45. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
  • FIGURE 46. GERMANY IONM MARKET ($MILLION), 2014-2022
  • FIGURE 47. FRANCE IONM MARKET ($MILLION), 2014-2022
  • FIGURE 48. UK IONM MARKET ($MILLION), 2014-2022
  • FIGURE 49. ITALY IONM MARKET ($MILLION), 2014-2022
  • FIGURE 50. SPAIN IONM MARKET ($MILLION), 2014-2022
  • FIGURE 51. REST OF EUROPE IONM MARKET ($MILLION), 2014-2022
  • FIGURE 52. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
  • FIGURE 53. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
  • FIGURE 54. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
  • FIGURE 55. JAPAN IONM MARKET ($MILLION), 2014-2022
  • FIGURE 56. CHINA IONM MARKET ($MILLION), 2014-2022
  • FIGURE 57. INDIA IONM MARKET ($MILLION), 2014-2022
  • FIGURE 58. SOUTH KOREA IONM MARKET ($MILLION), 2014-2022
  • FIGURE 59. AUSTRALIA IONM MARKET ($MILLION), 2014-2022
  • FIGURE 60. REST OF ASIA-PACIFIC IONM MARKET ($MILLION), 2014-2022
  • FIGURE 61. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
  • FIGURE 62. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
  • FIGURE 63. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
  • FIGURE 64. BRAZIL IONM MARKET ($MILLION), 2014-2022
  • FIGURE 65. SOUTH AFRICA IONM MARKET ($MILLION), 2014-2022
  • FIGURE 66. SAUDI ARABIA IONM MARKET ($MILLION), 2014-2022
  • FIGURE 67. REST OF LAMEA IONM MARKET ($MILLION), 2014-2022
  • FIGURE 68. MEDTRONIC: NET SALES, 2013-2015 ($MILLION)
  • FIGURE 69. MEDTRONIC: NET SALES, BY SEGMENT, 2015 ($MILLION)
  • FIGURE 70. MEDTRONIC: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
  • FIGURE 71. NATUS MEDICAL: NET SALES, 2013-2015 ($MILLION)
  • FIGURE 72. NATUS MEDICAL: NET SALES, BY SEGMENT, 2015 ($MILLION)
  • FIGURE 73. NATUS MEDICAL: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
  • FIGURE 74. NIHON KOHDEN: NET SALES, 2013-2015 ($MILLION)
  • FIGURE 75. NIHON KOHDEN: NET SALES, BY SEGMENT, 2015 ($MILLION)
  • FIGURE 76. NIHON KOHDEN: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
  • FIGURE 77. NUVASIVE: NET SALES, 2013-2015 ($MILLION)
  • FIGURE 78. NUVASIVE: NET SALES, BY SEGMENT, 2015 ($MILLION)
  • FIGURE 79. NUVASIVE: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
Back to Top